Last checked at 
16 Sep 2020 07:05
BIOPHARMA CREDIT PLC
(THE "COMPANY")
Appointment of New Director
The Company is pleased to announce the appointment of Rolf Soderstrom as a non-executive Director, with effect from 16 September 2020.
Rolf has over 30 years' strategic and operational experience in finance including M&A, fundraisings and disposals and is currently Senior Independent Director of Ergomed plc and Chair of its Audit and Risk Committee and External Independent Director of Sosei Group Corporation, which is listed on the Tokyo Stock Exchange, both of which are companies in the life sciences sector. From 2008 to 2018, Mr Soderstrom was CFO of BTG plc and helped drive the successful transformation of the company into a fully integrated global manufacturing and sales organisation focused on specialist healthcare. He was previously Divisional Finance Director at Cobham Plc and Director of Corporate Finance at Cable & Wireless Plc and qualified as a chartered accountant at PricewaterhouseCoopers.
Publicly quoted directorships held by Mr Soderstrom within the last five years are as follows:
Company
| Position |
Sosei Group Corporation
| External Independent Director and member of audit committee
|
Ergomed plc
| Non-executive Director, Senior Independent Director, Chair of the Audit and Risk Committee and member of Remuneration and Nomination Committees
|
BTG plc | Chief Financial Officer
|
There are no other details required to be disclosed under LR 9.6.13R (2) to (6) of the Financial Conduct Authority Listing Rules.
16 September 2020
LEI: 213800AV55PYXAS7SY24